Bereich
Kardiologie
KARDIO · Dept. I
SWISS TAVI
04.11.2024Prospective, National, Multi-Center Registry of Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI) in Switzerland (SwissTAVI)
Register - 04.11.2024 - 30.12.2040
Laufend
Mitarbeiter/innen: Haager Philipp, Vetsch Susanne, Maeder Micha
A phase 3 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of Amyloid Depleter ALXN2220 in adult participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
01.10.2024
Klinische Forschung - 01.10.2024 - 31.12.2029
Geplant
Projektleitung: Ehl Niklas
Mitarbeiter/innen: Vetsch Susanne
Pulmonary Vein Isolation with Pulsed-Field Ablation with versus without Posterior wall ablation in Patients with Symptomatic Persistent Atrial Fibrillation
17.09.2024A multicentre randomised clinical trial comparing two ablation strategies for the treatment of persistent AF (PVI only or PVI+ posterior wall ablation). IC: persistent AF, (N)OAK EC: atrial interventions, o. atrium >60mm, TAVI, Ml, >NYHA III, LVEF...
Klinische Forschung - 17.09.2024 - 17.09.2027
Laufend
Projektleitung: Franzeck Florian M
Mitarbeiter/innen: Meier Jessica, Vetsch Susanne
Textile ECG electrodes for long-term monitoring (Tex3CG)
01.07.2024The objective of this project is to evaluate and compare the signal quality of electrocardiogram (ECG) signals acquired by adhesive textile ECG electrodes (Tex) using adhesive gel electrodes (Gel) as a reference system.
Klinische Forschung - 01.07.2024 - 31.12.2024
Laufend
Projektleitung: Annaheim Simon, Ammann Peter
Mitarbeiter/innen: Meier Jessica
Hemodynamic characteristics of bendopnea – pathophysiological basis of a novel symptom in heart failure patients
01.07.2024The present project has several objectives. Our main goal is to evaluate the hemodynamic characteristics in particular the mean pulmonary artery wedge pressure (mPAWP) of patients with versus without bendopnea and those with high (supramedian) vers...
Klinische Forschung - 01.07.2024 - 30.06.2026
Laufend
Projektleitung: Maeder Micha
Mitarbeiter/innen: Schneider Irene
FANTOM
06.05.2024To evaluate the continued safety and performance of the Reva Fantom Sirolismus-Eluting Bioresorbable Coronary Scaffold in nativ coronary arteries that includes incorporation of a deformable expansion technologgy and an enhanced scaffold material (Tyr...
Klinische Forschung - 06.05.2024 - 30.06.2030
Laufend
Projektleitung: Rigger Johannes
Mitarbeiter/innen: Fink Karin, Schneider Irene
Carity Study
01.12.2023CARITY: A targeted approach to ensuring CARe and ActivITY persistence in mid- to older-age persons during and after cardiac rehabilitation following a cardiovascular event or intervention
Klinische Forschung - 01.12.2023 - 01.12.2025
Laufend
Projektleitung: Buser Marc
Mitarbeiter/innen: Vetsch Susanne
Vista Study
23.10.2023prospective, observational, global, multicenter study: The objective of the VISTA Study is to evaluate the safety and performance of the Navitor valve in a realworld setting. This study is intended to satisfy post-market clinical follow-up require...
Klinische Forschung - 23.10.2023 - 30.10.2030
Laufend
Projektleitung: Haager Philipp K.
Mitarbeiter/innen: Vetsch Susanne
The Selution DeNovo Study
28.09.2023A prospective, randomized, multicenter, international, open, clinical study in which the SELUTION DEB strategy was compared with the DES strategy. Study objectives: 1) At 1 year, to demonstrate non-inferiority for TVF of a treatment strategy wi...
Klinische Forschung - 28.09.2023 - 28.09.2028
Laufend
Projektleitung: Rigger Johannes
Mitarbeiter/innen: Meier Jessica, Schneider Irene
Immunopathological pathways underlying myocarditis and inflammatory cardiomyopathy – an exploratory study
24.07.2023Primary objective: Analysis of cardiac antigen- and microbiota-reactive CD4+ T cell and B cell response during development of cardiac inflammation. Secondary objectives: Analysis of clinical data, cardiac imaging and immunological parameters (HLA de...
Klinische Forschung - 24.07.2023 - 24.07.2024
Automatisch geschlossen
Projektleitung: Ludewig Burkhard
Mitarbeiter/innen: Rickli Hans, Maeder Micha, Vetsch Susanne
Swiss Cardiac Amyloidosis Registry
01.07.2023The aim of the Swiss-CARE registry is a comprehensive collection of clinical data and a follow-up of patients diagnosed with cardiac amyloidosis. Patients with and without therapy will be included in the registry. This will allow us to better under...
Register - 01.07.2023 - 01.07.2033
Laufend
Projektleitung: Ehl Niklas
Mitarbeiter/innen: Schneider Irene
Swiss Secondary Prevention and Rehabilitation Registry: SwissPR
01.07.2023The rationale of this prospective longitudinal cohort study is to determine the short and long-term effects of an ambulatory cardiac rehabilitation program on key cardiovascular benchmark performance measures and its effects on major adverse cardiova...
Register - 01.07.2023 - 31.12.2040
Laufend
Projektleitung: Buser Marc
Mitarbeiter/innen: Schneider Irene
Oceanic AF
01.06.2023A multicenter, international, randomized, active comparator-controlled, double-blind, doubledummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of the oral FXIa inhibitor asundexian (BAY 2433334) with apixaban for the preve...
Klinische Forschung - 01.06.2023 - 30.06.2024
Abgeschlossen
Projektleitung: Rickli Hans
Mitarbeiter/innen: Fink Karin, Vetsch Susanne
AmplatzerTM PFO Occluder and AmplatzerTM TalismanTM PFO Occluder PAS (“PFO PAS”) AmplatzerTM PFO Occluder and AmplatzerTM TalismanTM PFO Occluder Post Approval Study
01.06.2023PFO PAS is a singel arm, multinational post-market study in patients with PFO after ischemic stroke (paradoxical embolism). Screening via PFO colloquium. Study Objectives; To demonstrate safety of the Amplatzer PFO Occluder and Amplatzer Talisman P...
Klinische Forschung - 01.06.2023 - 01.06.2028
Laufend
Projektleitung: Chronis Joannis
Mitarbeiter/innen: Meier Jessica, Vetsch Susanne
OCEAN
01.05.2023A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein (a).
Klinische Forschung - 01.05.2023 - 31.12.2024
Abgebrochen
Projektleitung: Bilz Stefan
Mitarbeiter/innen: Räss Andrea, Rickli Hans, Vetsch Susanne
AMGEN202100057
01.05.2022A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD). The purpose of the study is to characterize the distribution o...
Klinische Forschung - 01.05.2022 - 31.03.2023
Abgeschlossen
Projektleitung: Rickli Hans
Mitarbeiter/innen: Vetsch Susanne, Bilz Stefan, Räss Andrea
MitraSwiss Register
01.04.2022A longitudinal observational study of patients treated with the MitraClip system in Switzerland
Register - 01.04.2022 - 31.12.2030
Laufend
Projektleitung: Haager Philipp
Mitarbeiter/innen: Schneider Irene
SOS AMI Selatogrel
10.01.2022Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjec...
Klinische Forschung - 10.01.2022 - 14.01.2026
Laufend
Projektleitung: Maeder Micha
Mitarbeiter/innen: Vetsch Susanne, Fink Karin
SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)
21.10.2021This study is a single armed, prospective, multi-center, observational study Planned: up to 40 study sites in the EU and selected non-EU-countries
Klinische Forschung - 21.10.2021 - 31.12.2026
Laufend
Projektleitung: Rigger Johannes
Mitarbeiter/innen: Vetsch Susanne, Fink Karin
CARE-HK in HF Registry
30.09.2021This study is a multinational, multicentre, non-interventional, cohort study of assessment and treatment guideline recommendations in HF patient care in a real-world setting.
Klinische Forschung - 30.09.2021 - 31.12.2025
Abgeschlossen
Projektleitung: Maeder Micha
Mitarbeiter/innen: Vetsch Susanne, Schneider Irene